The Seventh Circuit recently confirmed that Actavis is the appropriate framework to assess biosimilar patent settlements, despite the differences in the regulatory structure—the first appellate court ruling on this issue. In...more
The Ninth Circuit has held that a putative class of nationwide consumers that brought damages claims under California law was erroneously certified. Until now, class actions asserting claims for plaintiffs across the country...more
10/13/2021
/ Anti-Competitive ,
Apple ,
Cartwright Act ,
Cell Phones ,
Damages ,
Direct Purchasers ,
Illinois Brick ,
Indirect Purchasers ,
IP License ,
Motion to Dismiss ,
Price-Fixing ,
Qualcomm ,
Section 2 ,
Semiconductors ,
Sherman Act